<p>Extrawell Pharmaceutical Holdings Ltd. has announced the resignation of Mr. Fang Lin Hu as Independent Non-Executive Director, along with his roles as chairman and member of various board committees, effective 20 January 2026. Ms. Yang Xiaorong has been appointed as a new Independent Non-Executive Director and committee member. Ms. Jin Song has been named chairman of the Audit and Remuneration Committees. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Extrawell Pharmaceutical Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260120-11996401), on January 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

159837

159992

159506

Reuters

E Fund CSI Biotechnology Theme ETF

Yinhua CSI Innovative Drugs Industry ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

E Fund CSI 300 Health Care ETF

EXTRAWELL PHAR

China Merchants CSI Biotechnology Theme ETF

ChinaAMC CSI Biotechnology Theme ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Bosera Hang Seng SCHK Innovative Drug Select ETF

Guotai CSI Bio-medicine ETF

E Fund Hang Seng SCHK Innovative Drug ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Guotai SSE STAR Brand Name Drug ETF

China Universal 800 Health Care ETF

ChinaAMC SSE STAR Biology and Medicine ETF

Minsheng Royal CSI Biotechnology Theme ETF

Extrawell Pharmaceutical Appoints Yang Xiaorong as Independent Non-Executive Director